Upregulation of the protective Nrf2 antioxidant system and reduction in the NLRP3 inflammasome represents a novel and promising approach to aortic aneurysm treatment; however, clinical efficacy has yet to be established. Here, NLRP3 is linked to aortic aneurysm.